Significant Ownership of NORTH RUN CAPITAL, LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for NORTH RUN CAPITAL, LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Boston, MA
- Manager signature
- /s/ Michael Fisher - Michael Fisher / Attorney-in-Fact for Thomas B. Ellis and Todd B. Hammer, Members of General Partner
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow NORTH RUN CAPITAL, LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from NORTH RUN CAPITAL, LP
Significant Ownership of NORTH RUN CAPITAL, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LNSR | LENSAR, Inc. | Common Stock, $0.01 par value | 56% | $188,014,179 | 13,535,938 | ELLIS THOMAS B | 23 Mar 2025 | ||
| SCND | Scientific Industries, Inc. | Common Stock, par value $0.05 per share | 10% | $880,328 | 1,189,632 | 0% | North Run Capital, LP | 30 Sep 2025 | |
| TELA | TELA Bio, Inc. | Common Stock, $0.001 par value per share | 9.3% | $3,608,839 | +$1,666,000 | 3,682,489 | +86% | North Run Capital, LP | 31 Mar 2025 |
Schedules 13D/G Reported by NORTH RUN CAPITAL, LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.